Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apoptosis in liver disease.

Jörn M Schattenberg1, Peter R Galle, Marcus Schuchmann

  • 1I. Medizinische Klinik und Poliklinik, Johannes Gutenberg Universität, Mainz, Germany.

Liver International : Official Journal of the International Association for the Study of the Liver
|September 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Qualitative Evaluation of Fatigue and Pruritus Among Patients with Primary Biliary Cholangitis.

Advances in therapy·2026
Same author

Fibrosis-4 index and cardiac remodelling in the general population: The STANISLAS and African-PREDICT cohorts.

American journal of preventive cardiology·2026
Same author

Risk of metabolic dysfunction-associated steatotic liver disease and hepatic fibrosis: a large-scale study from the Middle East.

International journal of obesity (2005)·2026
Same author

Hearing loss and executive functions - results from a population-based cohort study.

PloS one·2026
Same author

Validated Early Detection Metrics Reduce the Population Requiring Liver Fibrosis Screening.

Gastroenterology·2026
Same author

Propelling MASLD trials into the era of non-invasive tests.

The lancet. Gastroenterology & hepatology·2026

Programmed cell death, or apoptosis, is a tightly regulated process crucial for tissue homeostasis. Dysregulation of apoptosis contributes to liver diseases like hepatocellular carcinoma.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Pathophysiology

Background:

  • Apoptosis, or programmed cell death, was first described in 1972, revolutionizing the understanding of cellular processes.
  • Key signaling pathways and proteins involved in apoptosis have been identified, leading to a Nobel Prize in Physiology or Medicine.
  • The study of apoptosis has significantly altered our understanding of liver diseases.

Purpose of the Study:

  • To review recent advances in hepatocellular apoptosis signaling.
  • To discuss the implications of dysregulated apoptosis in hepatic pathophysiology.
  • To highlight the role of apoptosis in liver diseases such as hepatocellular carcinoma.

Main Methods:

  • Review of literature on apoptosis signaling pathways.

Related Experiment Videos

  • Analysis of receptor-dependent and receptor-independent apoptosis mechanisms.
  • Examination of the role of p53 in apoptosis induction.
  • Discussion of pro- and antiapoptotic signaling integration.

    • Main Results:

    • Apoptosis involves cell surface death receptors and intracellular signaling cascades.
    • Receptor-independent apoptosis can be triggered by DNA-damaging agents via p53.
    • Apoptosis is a highly regulated process that avoids inflammatory responses, unlike necrosis.
    • Dysregulation of apoptosis is implicated in liver diseases, including acute liver failure and hepatocellular carcinoma.

    Conclusions:

    • Understanding hepatocellular apoptosis signaling is critical for liver disease research.
    • Disruption of apoptotic pathways contributes to the development of hepatic pathologies.
    • Targeting apoptosis pathways may offer therapeutic strategies for liver diseases.